Prot# VCH 916-103: A Phase IB, Multicenter, Randomized, Double-Blinded, and Placebo-Controlled Study of the Antiviral Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Doses of VCH-916 in Treatment Naive Subjects with Chronic Hepa